Amgen Eyes New Trial After Regeneron's $407M Antitrust Win

By Cara Salvatore · July 11, 2025, 8:50 PM EDT

Amgen urged a Delaware federal judge in documents made public Friday to overturn a nearly $407 million antitrust and tortious-interference verdict in favor of Regeneron, saying there was a serious lack...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login